US › Healthcare

OSR Holdings Inc (OSRH)

US · Healthcare · Biotechnology

$0.46+3.34%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$484,057

Revenue YoY

-36.4%

Net profit

$-2.9M

Profit YoY

+74.3%

EPS

$-0.09

Net margin

-605.6%

Key statistics

Market cap

$15.7M

P/E

14.9

Forward P/E

0.0

P/B

0.15

Book value

$3.12

EPS (TTM)

$0.03

52-week high

$1.24

52-week low

$0.30

50-day MA

$0.40

200-day MA

$0.54

Beta

0.72

Analyst view

with an average price target of $10.00.

Shareholding

Insiders

48.97%

Institutions

0.83%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.30%
XTX Topco Ltd	0.17%
The Toronto-Dominion Bank	0.11%
Vanguard Capital Management, LLC	0.11%
Vanguard Fiduciary Trust Co	0.05%
StoneX Group Inc	0.04%
Mint Tower Capital Management B.V.	0.02%
UBS Group AG	0.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for OSR Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.